Search
-
News
MSK investigators have shown that a gene mutation linked to many kinds of cancer can also cause birth defects of the nervous system.
… Friday, February 26, 2016 Summary MSK investigators have shown that a mutation in a gene called PTEN that’s linked to many kinds of cancer can also cause birth defects of the nervous system. Their research unveils the mechanism by which the mutation affects cell shape and prevents cells from properly
-
Clinical Trial
… Full Title A Phase 1, Multicenter, Open-label Study to Evaluate the Safety and Preliminary Efficacy of BMS-986393 in Novel Combinations in Participants with Relapsed and/or Refractory Multiple Myeloma and Determine the Recommended Dose for Each Add-on Investigational Component Purpose Researchers want
-
Event
… Cycle for Survival is the official rare cancer fundraising program of Memorial Sloan Kettering Cancer Center (MSK), which means that 100% of every dollar raised goes directly to research at MSK. Join us to ride stationary bikes and accelerate progress for people with rare cancer around the world. How
-
The Quaid Morris Lab
… Job Title Associate Professor, Computer Science, University of Toronto
-
The goal of the Robert and Kate Niehaus Center for Inherited Cancer Genomics is to develop early prevention and detection methods as well as targeted treatments for hereditary cancers.
… To investigate the hereditary causes of cancer, germline (inherited) DNA sequences are generated for groups of people who are affected by, or at risk for, inherited cancers. These projects usually originate within the Niehaus Center but may be performed in collaboration with other investigators at MSK
-
Health Outcomes
… Job Title Senior Data Analyst Email [email protected] Office Phone 646-888-8263
-
Our ovarian cancer nomogram is an online tool that can be used to help predict the chance that a patient will not survive five years after primary surgery for epithelial ovarian cancer.
… Our ovarian cancer nomogram is an online tool that can be used to help predict the chance that a patient will not survive five years after primary surgery for epithelial ovarian cancer. Who Can Use This Tool? This tool can be used primarily by physicians to help them counsel patients, determine clinical
-
-
News
Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk of bankruptcy and debt. Victoria Blinder, MD, medical oncologist at Memorial Sloan Kettering, conducted a longitudinal study of a racially and ethnically diverse sample of employed women undergoing treatment for stage I-III breast cancer in New York City. For more information on this study, published in Health Affairs on February 6, 2017, and to speak with the study author, contact [email protected].
… Tuesday, February 7, 2017 Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk
-
… Job Title Nurse Practitioner I began my career at Memorial Sloan Kettering Cancer Center as a registered nurse in the colorectal cancer service in 2006 and have since become a board-certified nurse practitioner specializing in colorectal cancer treatment and survivorship. In my role with MSK’s Adult